| Serial Number | 97599709 |
| Word Mark | NANT CANCER VACCINE |
| Filing Date | Tuesday, September 20, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 3, 2024 |
| Registration Number | 7491160 |
| Registration Date | Tuesday, September 3, 2024 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 18, 2024 |
| Goods and Services | pharmaceutical preparations and substances for the treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases and cancer for scientific, clinical, medicinal, therapeutic, and diagnostic purposes; pharmaceutical preparations and substances for the prevention, diagnosis, and treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases and cancer; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases and cancer; biological preparations for medical purposes, namely, vaccine preparations; low-dose chemotherapeutics, low dose radiopharmaceutical preparations, and personalized neoepitope-targeted pharmaceutical preparations for medical use for the treatment of human diseases in the nature of non-cancerous neoplasia, immunologic-related diseases, and immunologic dysfunction, animal diseases, autoimmune diseases, infectious diseases, and cancer; anti-cancer preparations; vaccines; biological preparations, namely, cell-derived preparations, cell therapeutics, monoclonal antibodies, cytokines, immune modulators, low-dose chemotherapeutics, low-dose radiation therapeutics, antibodies, fusion proteins, peptide and cytokine biological preparations, vaccines, personalized neoepitope-based therapeutics, and natural killer cell derived preparations, for the treatment of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, autoimmune diseases, infectious diseases, animal diseases, and cancer for clinical, medicinal, therapeutic, and veterinary purposes; kits comprising cell cultures, reagents and related instructions, for use in the treatment and prevention of non-cancerous neoplasia, immunologic-related diseases, immunologic dysfunction, autoimmune diseases, infectious diseases, animal diseases and cancer, for clinical, medicinal, therapeutic and veterinary purposes |
| NOT AVAILABLE | "CANCER VACCINE" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 26, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, July 19, 2022 |
| First Use In Commerce Date | Tuesday, July 19, 2022 |
| Party Name | Nant Holdings IP, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Culver City, CA 92032 |
| Party Name | Nant Holdings IP, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Culver City, CA 92032 |
| Party Name | Nant Holdings IP, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Culver City, CA 92032 |
| Event Date | Event Description |
| Friday, September 23, 2022 | NEW APPLICATION ENTERED |
| Monday, September 26, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 29, 2023 | ASSIGNED TO EXAMINER |
| Monday, August 21, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, August 21, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, August 21, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 21, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, November 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 15, 2024 | FINAL REFUSAL WRITTEN |
| Thursday, February 15, 2024 | FINAL REFUSAL E-MAILED |
| Thursday, February 15, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, May 14, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, May 14, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, May 14, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, May 14, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, May 14, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, May 29, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 18, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 18, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 3, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 3, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |